LY3009120

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3009120, covering 2019-12-27 to 2019-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body [Phase 1]

See pricing